NDC 50474-570 – Briviact
Brivaracetam 50 mg/1 · Tablet, Film Coated · Oral
Product NDC50474-570
Product details
Active ingredients
- Brivaracetam 50 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 50474-570-09 | 100 BLISTER PACK in 1 CARTON (50474-570-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK | May 12, 2016 |
| 50474-570-14 sample | 1 BLISTER PACK in 1 CARTON (50474-570-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK | May 12, 2016 |
| 50474-570-66 | 1 BOTTLE in 1 CARTON (50474-570-66) / 60 TABLET, FILM COATED in 1 BOTTLE | May 12, 2016 |
Recalls mentioning this NDC
- D-0591-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Briviact products
- 50474-370 Brivaracetam 10 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-470 Brivaracetam 25 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-670 Brivaracetam 75 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-770 Brivaracetam 100 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-870 Brivaracetam 10 mg/mL · Solution · UCB, Inc.
- 50474-970 Brivaracetam 50 mg/5mL · Injection, Suspension · UCB, Inc.